United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has successfully completed inspection of Lupin’s Goa facility in March, 2018. There were no critical or major observations in the inspection.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.